Business
First patient dosed in phase 3 TACTI-004 lung cancer trial
First patient dosed in phase 3 TACTI-004 lung cancer trial
About this update from Immutep Ltd
[{"type":"text","content":"Immutep Ltd has released a press release. View Attachment","length":225,"tagName":"div"}]